{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:32:26Z","timestamp":1790386346625,"version":"4.1.0"},"reference-count":17,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T00:00:00Z","timestamp":1279584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Toll\u2010like receptor 2 gene (<jats:italic>TLR2<\/jats:italic>) \u201316934A&gt;T polymorphism has been shown to be associated with severity of atopic dermatitis (AD) as measured using severity scoring of atopic dermatitis (SCORAD) index. Moreover, <jats:italic>TLR2<\/jats:italic>\u201316934A&gt;T polymorphism has been associated with atopy and allergic disorders in farmers\u2019 children.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> The aim of this study was to evaluate an association between <jats:italic>TLR2<\/jats:italic>\u201316934A&gt;T polymorphism and AD phenotype, including disease severity and concomitant atopic diseases, or potential serum markers of AD severity and also to find a molecular background of the clinical associations.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Genotyping for <jats:italic>TLR2<\/jats:italic>\u201316934A&gt;T polymorphism was performed in 130 consecutive adult ambulatory patients with AD. Total serum (TS) IgE levels, serum tryptase, plasma interleukin\u20106 and C\u2010reactive protein were measured. In addition, luciferase assay and electrophoretic\u2010mobility shift assay were conducted to assess the effect of \u201316934A&gt;T polymorphism on transcriptional activity.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> There was an inverse association of <jats:italic>TLR2<\/jats:italic>\u201316934TT genotype and\/or \u201316934T allele with SCORAD, but not with TS IgE, tryptase or inflammatory markers. Interestingly, \u201316934AA genotype and\/or \u201316934A allele were overrepresented in AD patients with concomitant asthma or a family history of atopy. In a subgroup analysis, <jats:italic>TLR2<\/jats:italic>\u201316934A&gt;T polymorphism was associated with SCORAD, asthma, allergic conjunctivitis or family history of atopy in AD patients with TS IgE \u2265106\u2003IU\/mL but not in those having TS IgE &lt;106\u2003IU\/mL. Functional analyses showed that <jats:italic>TLR2<\/jats:italic>\u201316934T allele is associated with higher luciferase activity in human monocytic THP\u20101 cells and preferential binding of the THP\u20101\u2010derived nuclear protein.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold>  <jats:italic>TLR2<\/jats:italic>\u201316934A&gt;T polymorphism could be a genetic predictor of AD severity, the coexistence of asthma or atopic conjunctivitis as well as a family history of atopic diseases, especially in subjects having higher TS IgE. <jats:italic>TLR2<\/jats:italic>\u201316934A&gt;T polymorphism affects transcriptional activity, which may at least in part account for the clinical associations observed for the \u201316934A&gt;T polymorphism.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2010.03812.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T09:31:05Z","timestamp":1279618265000},"page":"715-721","source":"Crossref","is-referenced-by-count":45,"title":["An association of <i>TLR2<\/i>\u201316934A&gt;T polymorphism and severity\/phenotype of atopic dermatitis"],"prefix":"10.1111","volume":"25","author":[{"given":"DP","family":"Potaczek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nastalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Wojas\u2010Pelc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,12]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247298"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03419.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2009.02066.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08972.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03351.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.12.374"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2004.03757.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.10.010"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hani\ufb01n JM","year":"1980","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.12.8204"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01891.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01721.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.12.583"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.04.034"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2007.02831.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0627"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03428.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2010.03812.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2010.03812.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T06:36:45Z","timestamp":1697351805000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2010.03812.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.1111\/j.1468-3083.2010.03812.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03812.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,12]]}}}